Wilms’ tumor protein and FLT3‐internal tandem duplication expression in patients with de novo acute myeloid leukemia

References

• Murata Y, Kudoh T, Sugiyama H, Toyoshima K, Akiyama T. The Wilms tumor suppressor gene WT1 induces G1 arrest and apoptosis in myeloblastic leukemia M1 cells. FEBS Lett 1997;409:41–5
   PubMed Web of Science ®Google Scholar
• Kreidberg JA, Sariola H, Loring JM, Maeda M, Pelletier J, Housman D, et al.. WT-1 is required for early kidney development. Cell 1993;74:679–91
   PubMed Web of Science ®Google Scholar
• Maheswaran S, Englert C, Bennett P, Heinrich G, Haber DA. The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis. Genes Dev 1995;9:2143–65
   PubMed Web of Science ®Google Scholar
• Mayo MW, Wang CY, Drouin SS, Madrid LV, Marshall AF, Reed JC, et al.. WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene. EMBO J 1999;18:3990–4003
   PubMed Web of Science ®Google Scholar
• Hirose M. The role of Wilms’ tumor genes. J Med Invest 1999;46:130–40
   PubMedGoogle Scholar
• Reddy JC, Licht JD. The WT1 Wilms’ tumor suppressor gene: how much do we really know? Biochim Biophys Acta 1996;1287:1–28
   PubMed Web of Science ®Google Scholar
• Miwa H, Beran M, Saunders GF. Expression of the Wilms’ tumor gene (WT1) in human leukemias. Leukemia 1992;6:405–9
   PubMed Web of Science ®Google Scholar
• Brieger J, Weidmann E, Fenchel K, Mitrou PS, Hoelzer D, Bergmann L. The expression of the Wilms’ tumor gene in acute myelocytic leukemias as a possible marker for leukemic blast cells. Leukemia 1994;8:2138–43
   PubMed Web of Science ®Google Scholar
• Brieger J, Weidmann E, Maurer U, Hoelzer D, Mitrou PS, Bergmann L. The Wilms’ tumor gene is frequently expressed in acute myeloblastic leukemias and may provide a marker for residual blast cells detectable by PCR. Ann Oncol 1995;6:811–6
   PubMed Web of Science ®Google Scholar
• Bergmann L, Miething C, Maurer U, Brieger J, Karakas T, Weidmann E, et al.. High levels of Wilms’ tumor gene (wt1) mRNA in acute myeloid leukemias are associated with a worse long-term outcome. Blood 1997;90:1217–25
   PubMed Web of Science ®Google Scholar
• Inoue K, Sugiyama H, Ogawa H, Nakagawa M, Yamagami T, Miwa H, et al.. WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. Blood 1994;84:3071–9
   PubMed Web of Science ®Google Scholar
• Barragán E, Cervera J, Bolufer P, Ballester S, Martín G, Fernández P, et al.. Prognostic implications of Wilms’ tumor gene (WT1) expression in patients with de novo acute myeloid leukemia. Haematologica 2004;89:926–33
   PubMed Web of Science ®Google Scholar
• Lyman SD, Jacobsen SE. c-Kit ligand and Flt3 ligand: stem/progenitor cell factors with overlapping yet distinct activities. Blood 1998;91:1101–34
   PubMed Web of Science ®Google Scholar
• Abu-Duhier FM, Goodeve AC, Wilson GA, Care RS, Peake IR, Reilly JT Genomic structure of human FLT3: implications for mutational analysis. Br J Haematol 2001;113:1076–7
   Google Scholar
• Agne’s F, Shamoon B, Dina C, Rosnet O, Birnbaum D, Galibert F. Genomic structure of the downstream part of the human FLT3 gene: exon/ intron structure conservation among genes encoding receptor tyrosine kinases (RTK) of subclass III. Gene 1994;145:283–8
   PubMed Web of Science ®Google Scholar
• Drexler HG. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells. Leukemia 1996;10:588–99
   PubMed Web of Science ®Google Scholar
• Lisovsky M, Estrov Z, Zhang X, Consoli U, Sanchez-Williams G, Snell V, et al.. FLT3 ligand stimulates proliferation and inhibits apoptosis of acute myeloid leukaemia cells: regulation of Bcl-2 and Bax. Blood 1996;88:3987–97
   PubMed Web of Science ®Google Scholar
• Rombouts WJ, Blokland I, Löwenberg B, Ploemacher RE. Biological characteristics and prognosis of adult acute myeloid leukemia with internal tandem duplications in the Flt3 gene. Leukemia 2000;14:675–83
   PubMed Web of Science ®Google Scholar
• Abu-Duhier FM, Goodeve AC, Wilson GA, Gari MA, Peake IR, Rees DC, et al.. FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high-risk group. Br J Haematol 2000;111:190–5
   PubMed Web of Science ®Google Scholar
• Jaffe ES, Harris NL, Stein H, Vardiman JW. World Health Organization classification of tumors. Pathology and genetics of tumors of haemotopoietic and lymphoid tissues. Lyon: IARC Press; 2001
   Google Scholar
• Schlenk RF, Benner A, Hartmann F, del Valle F, Weber C, Pralle H, et al.. Risk-adapted postremission therapy in acute myeloid leukemia: results of the German multicenter AML HD93 treatment trial. Leukemia 2003;17:1521–8
   PubMed Web of Science ®Google Scholar
• Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156–9
   PubMed Web of Science ®Google Scholar
• van Dongen JJ, Macintyre EA, Gabert JA, Delabesse E, Rossi V, Saglio G, et al.. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia 1999;13:1901–28
   PubMed Web of Science ®Google Scholar
• Nakao M, Yokota S, Iwai T, Kaneko H, Horiike S, Kashima K, , et al.. Internal tandem duplication of the flt3 gene found in acute myeloid leukemia. Leukemia 1996;10:1911–8
   PubMed Web of Science ®Google Scholar
• Galimberti S, Guerrini F, Carulli G, Fazzi R, Palumbo GA, Morabito F, et al.. Significant co-expression of WT1 and MDR1genes in acute myeloid leukemia patients at diagnosis. Eur J Haematol 2004;72:45–51
   PubMed Web of Science ®Google Scholar
• Gorczyca W, Bigman K, Mittelman A, Ahmed T, Gong J, Melamed MR, et al.. Induction of DNA strand breaks associated with apoptosis during treatment of leukemias. Leukemia 1993;7:659–70
   PubMed Web of Science ®Google Scholar
• Bhalla K, Ibrado AM, Tourkina E, Tang C, Grant S, Bullock G, et al.. High-dose mitoxantrone induces programmed cell death or apoptosis in human myeloid leukemia cells. Blood 1993;82:3133–40
   PubMed Web of Science ®Google Scholar
• Menssen HD, Renkl HJ, Rodeck U, Maurer J, Notter M, Schwartz S, et al.. Presence of Wilms’ tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias. Leukemia 1995;9:1060–7
   PubMed Web of Science ®Google Scholar
• Menssen HD, Renkl HJ, Rodeck U, Kari C, Schwartz S, Thiel E. Detection by monoclonal antibodies of the Wilms’ tumor (WT1) nuclear protein in patients with acute leukemia. Int J Cancer 1997;70:518–23
   PubMed Web of Science ®Google Scholar
• Al-Adnani M, Williams S, Anderson J, Ashworth M, Malone M, Sebire NJ. Immunohistochemical nuclear positivity for wt1 in childhood acute myeloid leukemia. Fetal Pediatr Pathol 2007;26:193–7
   PubMed Web of Science ®Google Scholar
• Cilloni D, Gottardi E, de Micheli D, Serra A, Volpe G, Messa F, et al.. Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients. Leukemia 2002;16:2115–21
   PubMed Web of Science ®Google Scholar
• Schmid D, Heinze G, Linnerth B, Tisljar K, Kusec R, Geissler K, et al.. Prognostic significance of WT1 gene expression at diagnosis in adult de novo acute myeloid leukemia. Leukemia 1997;11:639–43
   PubMed Web of Science ®Google Scholar
• Frohling S, Schlenk RF, Breitruck J, Benner A, Kreitmeier S, Tobis K, et al.. Prognostic significance of activating FLT3 mutations in younger adults (16–60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm. Blood 2002;100:4372–80
   PubMed Web of Science ®Google Scholar
• Kottaridis PD, Gale RE, Frew ME, Harrison G, Langabeer SE, Belton AA, et al.. The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials. Blood 2001;98:1752–9
   PubMed Web of Science ®Google Scholar
• Whitman SP, Archer KJ, Feng L, Baldus C, Becknell B, Carlson BD, et al.. Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study. Cancer Research 2001;61:7233–9
   PubMed Web of Science ®Google Scholar
• King-Underwood L, Pritchard-Jones K. Wilms’ tumor (WT1) gene mutations occur mainly in acute myeloid leukemia and may confer drug resistance. Blood 1998;91:2961–8
   PubMed Web of Science ®Google Scholar